Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14378676 | 1.00 | LMNA (0.57) | LMNAKDM4EALDH1A1KMT2ARAB9A | |
| SCHEMBL7891625 | 0.88 | LMNA (0.50) | LMNAKDM4EALDH1A1KMT2ARAB9A | |
| SCHEMBL16001621 | 0.88 | LMNA (0.50) | LMNAKDM4EALDH1A1KMT2ARAB9A | |
| SCHEMBL2201028 | 0.87 | LMNA (0.57) | LMNAKDM4EALDH1A1KMT2ARAB9A | |
| SCHEMBL6318871 | 0.87 | KDM4E (0.49) | LMNAKDM4EALDH1A1KMT2ARAB9A | |
| SCHEMBL14216898 | 0.84 | KDM4E (0.46) | LMNAKDM4EALDH1A1KMT2ARAB9A | |
| SCHEMBL2776891 | 0.84 | LMNA (0.46) | LMNAKDM4EALDH1A1KMT2ARAB9A | |
| SCHEMBL2776488 | 0.84 | LMNA (0.46) | LMNAKDM4EALDH1A1KMT2ARAB9A | |
| SCHEMBL12481918 | 0.83 | KDM4E (0.42) | LMNAKDM4EALDH1A1KMT2ARAB9A | |
| SCHEMBL24908346 | 0.83 | KDM4E (0.58) | LMNAKDM4EALDH1A1KMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4682199-A1 | MEMBER, AND SEMICONDUCTOR MANUFACTURING?RELATED DEVICE | Daikin Industries, Ltd. (JP) | 2026-01-21 | — | — | EP | disclosed |
| CN-112585196-B | Film, film manufacturing method, laminate, and packaging material | ＡＧＣ株式会社 | 2023-09-08 | — | — | CN | disclosed |
| CN-112566966-B | Film manufacturing method, film, laminate, and packaging material | ＡＧＣ株式会社 | 2023-04-18 | — | — | CN | disclosed |
| CN-112585196-A | Film, method for producing film, laminate, and packaging material | ＡＧＣ株式会社 | 2021-03-30 | — | — | CN | disclosed |
| CN-112566966-A | Film manufacturing method, film, laminate, and packaging material | ＡＧＣ株式会社 | 2021-03-26 | — | — | CN | disclosed |
| US-9944754-B2 | Block copolymers for stable micelles | INTEZYNE TECHNOLOGIES, INC. (US) | 2018-04-17 | — | — | US | disclosed |
| US-9944752-B2 | Block copolymers for stable micelles | INTEZYNE TECHNOLOGIES, INC. (US) | 2018-04-17 | — | — | US | disclosed |
| US-9944754-B2 | Block copolymers for stable micelles | INTEZYNE TECHNOLOGIES, INC. (US) | 2018-04-17 | — | — | US | disclosed |
| US-9944752-B2 | Block copolymers for stable micelles | INTEZYNE TECHNOLOGIES, INC. (US) | 2018-04-17 | — | — | US | disclosed |
| US-20170253699-A1 | BLOCK COPOLYMERS FOR STABLE MICELLES | INTEZYNE TECHNOLOGIES, INC. | 2017-09-07 | — | — | US | disclosed |
| US-20080274173-A1 | Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery | INTEZYNE TECHNOLOGIES, INC. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080274173-A1 | Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery | INTEZYNE TECHNOLOGIES, INC. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080207913-A1 | Poly(ethylene glycol) containing chemically disparate endgroups | INTEZYNE TECHNOLOGIES (US) | 2008-08-28 | — | — | US | disclosed |
| US-20080207913-A1 | Poly(ethylene glycol) containing chemically disparate endgroups | INTEZYNE TECHNOLOGIES (US) | 2008-08-28 | — | — | US | disclosed |
| US-20080188638-A1 | Heterobifunctional poly(ethyleneglycol) containing acid-labile amino protecting groups and uses thereof | INTEZYNE TECHNOLOGIES (US) | 2008-08-07 | — | — | US | disclosed |
| US-20080188638-A1 | Heterobifunctional poly(ethyleneglycol) containing acid-labile amino protecting groups and uses thereof | INTEZYNE TECHNOLOGIES (US) | 2008-08-07 | — | — | US | disclosed |
| WO-2007127473-A2 | POLY (ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS | INTEZYNE TECHNOLOGIES, INC. (US) | 2007-11-08 | — | — | WO | disclosed |
| US-4742166-A | ALLYL OR METHALLYL; INTERMEDIATES FOR CROSSLINKING TUGIVE EXCELLENT PHYSICAL PROPERTIES | CIBA-GEIGY CORPORATION (US) | 1988-05-03 | — | — | US | disclosed |
| US-4604437-A | Polymer from substituted, unsaturated, bicyclic imide | CIBA-GEIGY CORPORATION (US) | 1986-08-05 | — | — | US | disclosed |
| US-4515962-A | Allyl or methallyl-bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid imides and bisimides | CIBA GEIGY CORPORATION (US) | 1985-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080188638-A1 | Heterobifunctional poly(ethyleneglycol) containing acid-labile amino protecting groups and uses thereof | LNPEP, GNE, DNPEP | LMNA 2247/4885KDM4E 2452/4885ALDH1A1 2599/4885 |
| US-20080274173-A1 | Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery | CLTB, SLC1A5, CLTA | LMNA 490/4885KDM4E 2218/4885ALDH1A1 3966/4885 |
| US-20080207913-A1 | Poly(ethylene glycol) containing chemically disparate endgroups | GNE, EPRS1, ALG1 | LMNA 2653/4885KDM4E 2894/4885ALDH1A1 2008/4885 |
| US-20170253699-A1 | BLOCK COPOLYMERS FOR STABLE MICELLES | ABCB4, CLTB, EPHA2 | LMNA 1456/4885KDM4E 4502/4885ALDH1A1 4634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.